SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Self " 3,020 found 🔀 AI-powered Shuffle
Blake Lively is seeking $8.04 million in legal fees from Justin Baldoni amid 'It Ends With Us' settlement
Blake Lively is asking a judge to award her over $8 million in attorneys' fees and litigation costs for having defended herself against Justin Baldoni's now-dismissed defamation lawsuit.
Building the Valley: Young Springdale man keeping lawns at bay as business grows
When Justin Burrell started landscaping in 2022, the then-14-year-old wasn’t old enough to drive himself to clients’ houses so he enlisted help from his parents. At first, he mowed lawns for some extra pocket change. Now, at 18, Burrell is working toward turn his Burrell Grounds and Services business into
Jalen Brunson receives praise from Knicks fans for offseason work
Jalen Brunson is wasting no time keeping himself in shape this offseason. He led the New York Knicks to the 2026 NBA championship on June 13, and the superstar guard is already working out 16 days later. A video of…
8-year Cowboys team leader retires after 12 NFL seasons
The Cowboys special teams ace has made a name for himself among the club's fans.
George Gresham, Health Care Union Powerhouse, Dies at 71
Until he lost an election last year amid accusations of self-enrichment, he was a longtime influential force in Democratic politics in New York.
Lizzo slams 'Khia Asylum' meme for 'flopping' pop stars: 'Weapon that targets only women'
Lizzo slammed the 'Khia Asylum' meme often use for 'flopping' pop stars: 'A tool to bully artists,' she said, calling the title itself 'backhanded' for mocking a 'pillar in the Black community.'
Scientists discover an unexpected way to make pancreatic cancer cells self-destruct
Researchers tested experimental PCAI compounds against pancreatic cancer cells and found they had powerful anticancer effects. One leading compound blocked more than 90% of cancer cell migration, suggesting it could help prevent the spread of tumors. Rather than suppressing cancer signaling, the treatment hyperactivated key pathways until the cells essentially self-destructed.
Careers That Shaped Biology
Every great scientific career begins with a question no one has been able to answer — and a scientist stubborn enough to keep asking it. This series looks back at the careers of some of HHMI’s most distinguished scientists — people whose contributions have changed what we know about life itself, and whose stories reflect the best of what science, and scientists, can be.
A $1000 PlayStation 6 No Longer Sounds Crazy, As Sony Doesn’t Intend To Sell Hardware At Significant Losses
The PlayStation 6 is set to launch at one of the most challenging times for consumer tech, if not the most challenging. With the rising prices of components, RAM and SSDs above all, manufacturers are having an extremely hard time keeping costs down, and with a bill of materials that is now close to $1000, there's a very high chance the system will cost way more than most anticipated. Adding fuel to the fires of speculation is Sony itself, as the company heavily suggested in a recent investor Q&A session that it won't heavily subsidize the system. "We regard hardware as the base […]
Mental health medications can cause heat sensitivity
Some drugs can impair the body’s ability to cool itself and require extra self-care.
Comcast plans to split into two public companies by spinning of NBCUniversal and Sky
Comcast is planning to split itself into two separate publicly traded companies by spinning off NBCUniversal and Sky
The ERs that can turn patients away
The hospital operator Nutex enriched itself by exploiting loopholes in laws meant to protect patients, STAT found.
FIFA Let Politics Win Over Football, Iran Paid The Price For Political Hypocrisy
Football's governing body has long sold itself as apolitical - like the IOC - an organisation above borders, above diplomacy, above conflict. But this World Cup has challenged that idea and changed perceptions about FIFA.
I'm a stay-at-home mom of 2. My 4 side gigs help me pay off debt.
Lana Ng left her marketing job in 2023 to take care of her children. Now, her four side gigs help her not lose herself in motherhood.
CD Projekt is rebranding as CD Projekt Red, but confusingly, CD Projekt Red is still CD Projekt Red
CD Projekt has rebranded itself as CD Projekt Red – or CD Projekt Red Spółka Akcyjna, to be precise.
Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Positive results from the MULBERRY Phase III trial showed that efzimfotase alfa (ALXN1850), an investigational enzyme replacement therapy, demonstrated a statistically significant and clinically meaningful improvement in bone health in children (2 to
El Niño Is Back—and It Could Cost Businesses Trillions. What Smart Leaders Are to Prepare
Dartmouth research makes the duration of the damage clear: economic losses from major El Niño events persist for five years after the event itself.
Govee's smart nugget ice maker makes every iced drink feel like a luxury
For some people, the ice in a beverage is almost as important as the drink itself. That's the audience Govee had in mind when designing its latest ice
AWS CEO says replacing young employees with AI is ‘one of the dumbest ideas’—and bad for business: ‘At some point the whole thing explodes on itself’
Amazon laid off 14,000 employees this fall, but CEO Andy Jassy denied the reductions were related to AI.
The Politics of the Instagram Story
Drive yourself crazy for the low price of $3.99 a month!
4 Marketing Lessons Every Business Can Learn From the 2026 FIFA World Cup
Nike, Adidas, Home Depot, and FIFA itself offer a powerful reminder: marketing success depends on far more than how much you spend.
GM hires talent from rivals to solve self-driving car problem
GM has made several key executive hires since 2025 and brought back Cruise alums to ramp up its self-driving tech development in personal cars.
Burcum: Sanford Health got what it wanted. Now comes the moment of truth.
From columnist Jill Burcum: The South Dakota health system has spent a decade trying to crack the Twin Cities health care market. With the North Memorial deal, it now has a chance to prove itself.
Andy Burnham distanced himself from UK Prime Minister Starmer, but may be stuck with his policies
Burnham, the former mayor of Greater Manchester who was sworn into Parliament hours after Starmer announced his resignation on Monday, will be constrained by the platform the center-left Labour Party was elected on that decisively ended 14 years of Conservative rule in 2024.
Andy Burnham distanced himself from UK Prime Minister Starmer, but may be stuck with his policies
Andy Burnham has set himself apart from the man he expects to replace as British prime minister
Trump posts new passport rendering — featuring a memorable photo of himself
President Donald Trump unveiled a new rendering of a special commemorative US passport bearing his likeness Friday, debuting a limited-edition passport to mark America’s 250th anniversary this year.
Vance Downplays Watergate and Compares Himself to Nixon
The vice president said that the scandal that ended Richard Nixon’s presidency would be “like a 12-hour news story” if it happened today and that the “deep state” had taken down Nixon.
Karl Stefanovic Speaks Out on Nine Exit After Tommy Robinson Scandal
The 'Today' host declares himself 'free' in a YouTube statement after Nine ends his contract following a deleted Tommy Robinson podcast episode.
JD Vance claims Diddy is 'not a Christian' after federal conviction
Sean "Diddy" Combs might have scored a reference in Vice President JD Vance's new book, but the politician is not eager to associate himself with the imprisoned music mogul.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
David P. O'Brien
About five years ago, David P. O'Brien had a comfortable position at Marsh & McLennan Cos., where he held the top post at the financial giant's Louisville, Ky., office. Despite the lofty rank, Mr. O'Brien found himself longing to be at a smaller company that had to work a little harder to land business. That desire led him away from Kentucky five years ago and to Cleveland, where he serves as executive vice president at business insurance agency Oswald Cos. "I left Marsh before it was en vogue," he said, referring to layoffs and defections at Marsh over the course of this year that followed accusations of bid rigging at the big firm. Above all, Mr. O'Brien, 38, wanted to work at a company that relied on its inventiveness, rather than its name, for business. He said he has found that at Oswald. "It causes you to be more creative, to be more resourceful," Mr. O'Brien said. For instance, an Oswald client seeking to do business internationally might be directed to the network of offices abroad run by competitors such as Marsh and Aon Risk Services Inc. "We're going to use whatever access into the market that makes the most sense for our clients," he said. Of course, using such a strategy can be dangerous for Oswald if its client decides to further a business relationship with one of the firms Oswald recommended. "That's the obvious question and why it's nontraditional," he said. "I think if we're good, and if we're bringing value to the client, then there's no risk. I'm not threatened by it." Imaginative business solutions of that type made his career move to Oswald from Marsh worthwhile. "It's very much a challenge," he said. "It helps you keep your edge. I'm all for the competition." John Jacunski, currently vice president and corporate controller at York, Pa., paper company PH Gladfelter Co., met Mr. O'Brien four years ago when Mr. Jacunski was at WCI Steel Inc. in Warren. So impressed was he with Mr. O'Brien's work for WCI that Mr. Jacunski has retained the Oswald executive at PH Gladfelter. "He's a young guy for the position he has, but he's done a great job for us," Mr. Jacunski said. Among his roles at Oswald, Mr. O'Brien leads the firm's client retention efforts and also serves as director of its property and casualty group. "You don't have the same human resources," he said of the job jump to Oswald. "You don't have, obviously, the safety net a big company has." But sometimes, it can be difficult to ascertain individual contributions when working at a big company. "I wanted to be able to see the end results of my work and my efforts," Mr. O'Brien said.
After my divorce, I rebuilt my life, starting with friendship
After my divorce, I felt lonely and had to make new friends. I learned a lot about friendship — and myself — in the process.
Scientists discover how a single cell builds a brain with 170 billion cells
How does a single cell build a brain with billions of precisely organized neurons? Researchers suggest that brain cells use their lineage—their cellular family tree—as a kind of positional map. Cells that come from the same ancestor stay near one another, helping the brain organize itself without relying solely on chemical signals.
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
Palo Alto Networks CEO: Workers are in 'Darwinian moment' with AI
"The challenge right now is 90% of the enterprise employees are not AI savvy," said Palo Alto Networks' CEO, who added that self-teaching is key.
Is Trump celebrating the country, or himself, on America’s 250th?
It was almost as if the last 250 years never happened.
Is Trump celebrating the country, or himself, on America’s 250th?
It was almost as if the last 250 years never happened.
When WA's behavioral health system failed her son, Blaine mom declared herself an unfit parent
A mother's experience with 'cycle of insufficient care' for troubled children in Washington
They poured fortunes into trying to join Congress
Of the most expensive self-funded congressional campaigns since 2000, only four out of 20 were successful.
Scientists Inserted A Gene Into Mice That's Older Than Animal Life Itself
Ancient genes, modern mice.
Google’s New $100 Speaker Makes a Weak Case for Gemini in the Home
The Google Home Speaker is the first new device of its kind to come from Alphabet Inc. in six years. In that time, Google has reshaped itself as an industry leader in artificial intelligence, with its Gemini platform now ubiquitous across consumer hardware like smartphones and web services like Search, Workspace and YouTube.
How to bet responsibly during the World Cup
With billions of more dollars and dozens of more games, this World Cup will be a bookmaker bonanza. Here's how to keep yourself safe while wagering.
To age better, we need to rethink health itself
Challenging conventional thinking has historically brought new ways to maximize health and improve quality of life while ageing. Here's what's needed now.
The Purpose Pivot: Activating Business Strategies to Reshape Systems
Our Purpose Pivot series continues with Ravneeta Consul ’06. As chief operating officer of Undue Medical Debt, Consul works on one of the most widespread and least visible financial burdens in the United States. The national nonprofit has abolished more than 40 billion dollars of medical debt for 27 million people across all 50 states, while also working to change how the system itself is understood and addressed.
Roku May Help Fox Avoid Aggregeddon
(Welcome to the “Most Important Story of the Week”, my bi-weekly strategy column analyzing the most important (but often not buzziest) news story of the last two weeks. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. Please subscribe.) Scrolling through links over the last week, I stumbled across this fun headline: Wow. Formula 1 (the sport, not the docu-series) is the perfect “dog not barking”. As a reminder, each week in my Streaming Ratings Report, I call out the shows that miss every viewership chart. I dub them “dogs not barking”—like the Sherlock Holmes mystery—because without any data, we forget they even exist. This is in contrast to something like, say, a film flop—cough The Mandalorian and Grogu cough—where even underperforming at the box office is widely discussed here, there and everywhere. In the US, Formula 1 is now in “no public viewership data, so not discussed” territory. After moving to Apple TV from its former home of ESPN, basically no one talks about it. Apple did publish an initial, unsourced, unsubstantiated, (dare I say unserious) datecdote claiming more folks are watching Formula 1 on Apple than ESPN, but we haven’t gotten any updates since. This stands in contrast to when the sport streamed on ESPN, and ESPN PR provided weekly viewership figures. Formula 1 was, at best, a niche sport in America—averaging 1.3 million viewers in the Big Data Plus era—but now it’s basically anonymous. (And yeah, after moving to Apple, I very, very, very much doubt its ratings increased.) Unfortunately, that story isn’t quite big enough to warrant a section in today’s “Most Important Story of the Week” column, but I wanted to call it out, because otherwise, no one else will! Certainly, no one will write articles about the silence/ratings decline, unlike when they wrote breathless articles connecting the rise in viewership to Netflix’s Drive to Survive, including Reuters just last month. (This is a topic I’ve tried to provide a moderate/nuanced/non-hyped take since 2022.) Anyway, on to this week’s issue. I was a bit worried I didn’t have a juicy topic, then the Murdochs went out and did their Murdoch thing: buying Roku. So that’s the story of the week, and it happens to touch on quite a few themes of the streaming wars and the disruption therein. I’ll cover that, plus why more consolidation in Hollywood media looks likely, more good news on the Hollywood labor front, whether we’ll see an uptick in production in Los Angeles, some Broadway and theme park news, cellphone prices going up in the third world (and possibly everywhere), and more. Subscribe Most Important Story of the Week - Another Big Media & Entertainment Merger The story of the week is clearly Fox is buying Roku for $22 billion. I read a lot of good strategy takes on why Fox bought this streaming TV device maker—and I’ll have mine below—but what fascinates me more is how this deal connects to quite a few themes of the streaming wars, linking to everything from the pace of M&A to “aggregeddon” to Netflix’s recent M&A actions/inactions to the shift to advertising from pure play streaming and more. The only topic I can’t really connect it to is my old theory, “never bet against Rupert Murdoch” because he isn’t the one who did this deal; his son Lachlan inked it. (Do I think he provided advice, even at his 95 years of age? Sure.) That plus I have one additional piece of strategy for all entertainment players, inspired by this deal. So let’s dive into all those topics, starting with why I like this deal. Roku is a Great M&A Buy
These are the 19 best Prime Day phone deals I'd actually buy myself
Prime Day 2026 has officially started. Save hundreds right now on smartphones, including the Google Pixel 10 Pro and Samsung Galaxy S26.
I’ve built hundreds of Lego sets. These Prime Day deals are worth building yourself
As an avid Lego builder, I found the best Amazon Prime Day deals on Lego Star Wars sets, brick-built plants and even F1 cars.
Trump-endorsed populist poised to become Colombia’s next president
The winner is a self-proclaimed representative of “the never-before-seen.”
Colts offensive line fixture lands in ‘NFL Top 100’ again
Colts offensive line anchor Quenton Nelson finds himself in the ‘NFL Top 100’ yet again.
Wicks working to show he's ‘worthwhile' for Eagles with a bet-on-himself deal
It might not be receiver by committee in Philadelphia after all. That’s if newly acquired Dontayvion Wicks has something to say about it.
Blending Creativity and Business with Emma Richey
Storytelling-based business owner Emma Richey chose to specialize in finance and securities analysis with the Oregon MBA to challenge herself analytically and pivot careers.
God of War Laufey Star Deborah Ann Woll Breaks Silence on a Massive 10-Year Secret: “I Still Pinch Myself”
Renowned actress Deborah Ann Woll, best known as Jessica Hamby in True Blood and Karen Page in Daredevil, has spoken with CGMagazine about her lead role in God of War Laufey as the titular character. In an interview conducted during Game Con Canada, Woll confirmed what Game Director Ariel Lawrence had revealed earlier this month: Head of Creative Cory Barlog had this game in mind even before the launch of God of War 2018, and there was already a poster featuring Laufey and Phranque (the cosmic cube). Related Story Unlocking the Snapdragon 8 Elite Gen 6 Pro’s Real Performance Will […]
Monday morning observations about JJ Wetherholt, Masyn Winn
Folks, I don’t think I got it today. I spent all of Thursday getting ready for a weekend trip, of course not giving myself enough time to do everything I wanted to do, so the entire day was hectic. I arrived at my destination that night, and then drank heavily for three straight nights. I […]
Mental health partnership aims to give young doctors in training the self-care skills to cope with stress of the job
Becoming a doctor requires long hours, over many years, often with a lot of stress. A mental health program at CU Anschutz aims to give young doctors the
5 Mario Kart habits players should stop doing immediately
You may be holding yourself back
Father’s Day brings attention to men’s health, self-care
As families celebrate fathers and father figures this weekend, experts say many men are still not prioritizing their own health.
Lion undergoes double cataract surgery
‘The surgery itself is almost identical to modern human cataract surgery.’
Suspect arrested after shooting, standoff at north Charlotte business
A suspect is facing charges after shooting into an occupied vehicle and barricading himself inside a local business.
I’ve built hundreds of Lego sets. These early Prime Day deals are worth building yourself
As an avid Lego builder, I found the best early Amazon Prime Day deals on Lego Star Wars sets, brick-built plants and even F1 cars.
Washington Wizards, Trae Young Situation Will Resolve Itself Soon
The Washington Wizards saw a ton of news last week, but there's no reason for the Trae Young situation to become a worry.
Chig Okonkwo Fitting with Washington Commanders On, Off the Field
The Washington Commanders added a major weapon to the offense this offseason with tight end Chig Okonkwo proving himself as a fit on and off the field
Opinion: Trump's 'Drill, baby, drill' serves himself, oil companies
“Drill, Baby Drill” domestic oil production was supposed to protect us from international price fixing, bad behavior in the Middle East. It hasn't.
Sunday Morning Showdown: Vacheron Constantin Overseas Self-Winding Vs. Girard-Perregaux Laureato Fifty 39mm
✓ Sunday Morning Showdown ✓ Vacheron Constantin's Overseas takes on Girard-Perregaux's Laureato Fifty ✓ Two stylish classics ✓ Vote here! ✓
Nintendo Switch Sports Resort confirms 100 Pin Bowling, here's a first look
Nintendo Switch Sports Resort, which was recent announced, has confirmed that 100 Pin Bowling will be included. Nintendo itself shared the news, posting a screenshot on its Japanese website. 100 Pin Bowling was a part of the original Wii Sports Resort. It’s still ultimately about bowling, but the mode is set up in a triangular formation and obviously has you...
Cooling hoodies help England staff combat World Cup heat
As the England players trained under the searing heat of the Kansas City sun on Saturday, manager Thomas Tuchel took a very different approach to keeping himself cool.
Luxury hotels have a new VIP guest: your dog
Morgan Owens, a wellness, media and lifestyle entrepreneur, recently checked herself and her 7-year-old bichon frise, Ralph, in for a staycation to the Lytle Hotel in Cincinnati. There, they watched
‘It’s not science, it’s coercion’: health experts decry RFK Jr order on hantavirus quarantine
Kennedy overrides CDC order saying an American who came into contact with hantavirus can self-quarantine
‘It’s not science, it’s coercion’: health experts decry RFK Jr order on hantavirus quarantine
Kennedy overrides CDC order saying an American who came into contact with hantavirus can self-quarantine
Frive meals founder: ‘My business saved my life’
Having nothing to wake up for led George Taylor down a self-destructive path. His microwave meal business gave him a purpose
Why some Russians are breaking with Putin as Ukraine war drags on
Russian President Vladimir Putin’s iron grip on power is being challenged by the war in Ukraine and his government’s authoritarian crackdowns. He finds himself in unfamiliar political territory, questioned by some of the country’s elite and embarrassed by Ukraine’s strikes into Russian cities. Compass Points moderator Nick Schifrin discusses the state of Russian politics with Arkady Ostrovsky.
First US patient enrolled in device study to reduce coronary microvascular dysfunction
The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.
U.S. Open: Dustin Johnson returned to the top, then vanished at Shinnecock
Dustin Johnson seemingly turned back the clock, getting himself in contention, until disaster struck.
Miami Heat or Boston Celtics? Predicting Giannis Antetokounmpo’s Landing Spot
Giannis Antetokounmpo is likely nearing the end of his tenure with the Milwaukee Bucks. Milwaukee’s self-imposed trade deadline for Antetokounmpo […]
Alogic Debuts New Touchscreen Monitors and Portable Displays With Mac Support
Alogic this week unveiled a new lineup of touchscreen displays that bring touch and stylus functionality to Macs, including the FOKUS interactive touchscreen series, the Aspekt Touch 27" monitor, and new Folio portable touchscreen displays. Aspekt Touch 27" While Apple has yet to release a touchscreen Mac, Alogic has established itself as one of the few display makers offering touch-enabled monitors designed to work with macOS.
Gov Sanders reveals 'major breakthrough' on education as red state positions itself as 'blueprint' for nation
Arkansas students show 7% proficiency gains under Gov. Sarah Sanders' LEARNS Act, with the governor hoping red and blue states will follow the blueprint.
Major grocery operator on the hook for $40M over pharmacy monkey business; $6M windfall for whistleblower
One of the largest food retailers in the world—and the fourth biggest in this country—got itself into hot water with the U.S. Department of Justice for allegedly cheating on drug prices it charges to federal healthcare programs.
WATCH: Dem candidate grilled on stock trading after being duped with selfie request
Former Rep. Elaine Luria was ambushed on video over her net worth allegedly growing over 2,000% during her four years serving in the U.S. Congress.
Hillsborough County wants to seek state review of Tampa Sports Authority stadium vote
Hillsborough County commissioners are weighing whether to ask Gov. Ron DeSantis to review potential ethics concerns involving members of the Tampa Sports Authority after a contentious sports board vote sparked intense allegations of self-dealing.
Saving the trees: Decades of work lead to UTC faculty publication in Science
The first American chestnut tree Dr. Hill Craddock ever saw was one he grew himself. He was about 15 years old, working out of a small greenhouse his father built beside their home. A neighbor gave him a handful of chestnut seeds and suggested Craddock try growing them.
I read JD Vance’s new book. It reveals more than he realizes.
The vice president pitches himself as a humble Catholic convert in a new memoir — but somehow skips the humility part when it comes to politics.
Mayo Clinic Q&A: Block some time out for health screenings
DEAR MAYO CLINIC: Since I turned 40, my clinic has been sending me a slew of reminders about men's health screenings. Are they really necessary? ANSWER: Yes! Blocking out some time for these important health screenings is one of the most important things you can do for yourself. Historically, men have been hesitant to seek […]
Why Is Sexual Health Still Overlooked in Chronic Pain Care?
Experts urge clinicians to address intimacy and sexual well-being routinely, noting that chronic pain often affects relationships, self-esteem, and quality of life.
Spider-Man faces off against the Hulk in 'Brand New Day' trailer: 'Didn't know you could get that big'
Is your Peter tingle activated? Spider-Man finds himself going up against the Hulk in the newest 'Brand New Day' trailer.
Yakuza Creator's New Game Seems To Have Lost Its Director After NetEase Reportedly Pulled Funding
Daisuke Sato is now describing himself as 'ex-Nagoshi Studio'
How Texas Tech played itself, and the Big 12 commissioner rose to meet his tenure-defining moment
As we turn the page on the Brendan Sorsby we look back at how Texas Attorney General Ken Paxton's threat unified the Big 12, and commissioner Brett Yormark pulled all the right levers to advocate for his member schools
Scientists discover spider that disguises itself as a parasitic fungus
Scientists have discovered a new Amazonian spider with an astonishing disguise: it looks like a parasitic fungus. The species, Taczanowskia waska, mimics both the appearance and behavior of the fungus, helping it stay hidden from predators and potentially catch prey more easily.
WHO Step-by-Step programme recognized as a promising innovation for mental health in humanitarian settings
WHO, in collaboration with the Pan American Health Organization (PAHO) and Lebanon’s National Mental Health Programme, showcased Step-by-Step at the World Bank Group’s biennial Fragility Forum in Washington, DC. The forum convened more than 1500 representatives from governments, international organizations and civil society to advance the development agenda in the world’s most fragile and crisis-affected communities. WHO was invited to demonstrate Step-by-Step – a digital self-help intervention for depression, alongside innovations presented by Stanford University and Google. The World Bank Group selected Step-by-Step from among more than 50 innovations that they reviewed in the lead up to the Forum.About Step-by-StepStep-by-Step is a free digital tool developed by WHO in collaboration with Lebanon’s National Mental Health Programme and other partners, that helps people manage depression and anxiety on their own, with light guidance from a trained supporter. It uses a picture-based story to walk users through evidence-based techniques for managing common mental health conditions. Users complete five modules, with weekly contacts – of around 15 minutes each – from a trained non-specialist helper, such as a community health worker.Evidence-basedClinical trials in Lebanon involving nearly 1250 participants – including 680 Lebanese participants and 569 Syrian participants – showed that Step-by-Step significantly reduced depression, anxiety and stress, and improved daily functioning. By the end of the programme, a reduction in depressive symptoms of more than 50% was reported by almost half (46%) of Lebanese participants and more than one third (37%) of Syrian participants compared to approximately 14% of those who did not use the programme. Cost-effectiveness analyses further suggest that Step-by-Step may offer a cost-saving response to depression in humanitarian emergencies in low- and middle-income countries.Used globallyStep-by-Step is already in use nationwide in Lebanon and Thailand, as part of each country’s mental health system. In India, the NGO – Kaya Guides – has adapted Step-by-Step for delivery through a widely used messaging app. Together, these programmes have provided thousands of people with evidence-based support for depression. The content is freely available from the WHO website for any organization or country to adapt for their own context.A new implementation guideThe Fragility Forum coincided with the recent launch of WHO’s new practical guide: Psychological self-help interventions: delivering self-help for individuals, featuring Step-by-Step and Doing What Matters in Times of Stress (WHO, 2026). The guide is designed to help governments, health workers, organizations and planners bring evidence-based mental health support to more people, particularly in low-resource and crisis-affected settings.
Latvia pilots citizen engagement in research grant evaluations
Latvia has introduced an element of citizen engagement to the evaluation of nationally funded research grants. The aim is to both create more connections between science and society, and to improve the quality of its evaluations. The move comes as research funders across Europe are experimenting with ways to improve evaluation processes in the face of a sharpened focus on science’s impact on society. Evaluators of grant applications submitted to Latvia’s Fundamental and Applied Research Programme (FLPP), the country’s main research funder, will this year have the option of consulting citizen feedback on challenges the public thinks science should focus on to inform their decisions. “In recent years, both public discussions and policy-level debates in Latvia have highlighted the importance of demonstrating how publicly funded research contributes to society, the economy and the resolution of real-world challenges,” said a source at the Latvian Council of Science (LCS), which manages the FLPP. “At the same time, research institutions themselves expressed interest in improving the project evaluation framework while continuing to ensure that funding is awarded to the highest-quality projects,” the source added. The citizen input comes from a survey that was conducted between 25 February and 16 March 2025, to which 1,737 people responded. It gathered information on what the public views as problem areas for Latvia, and the role of science and technology in providing solutions to these problems. A summary of these responses has been included as an annex to the FLPP 2026 call for proposals that evaluators can refer to, purely in an advisory manner, when judging proposals. Results from the survey show that the main problem areas identified by the public were in healthcare and public health, followed by the development of new treatment methods and medicines, and then digital technology, data security and cyber security. At the bottom of the list was research aimed at acquiring new knowledge about the universe, matter and the laws of nature. Further analysis looked at the public view of the possible role of science in solving these problems. The survey charted 4,167 individual responses based on open-ended questions that were derived from the participants’ answers. The analysis again found that medical and health sciences topped the scoring, with 788 responses referring to the field. Humanities and the arts were bottom of the list, with 625. Digging further into the details, the survey suggests citizens are aware of and concerned about a number of research areas. This includes technologies and innovation to improve the environment or reduce pollution, the development of modern military technologies and cybersecurity tools, and the development and application of artificial intelligence, among others. “We hope this initiative will help strengthen public trust in science and create a more meaningful dialogue between researchers and society,” the LCS source said, adding that it offers benefits to researchers, evaluators and to the general public. More space for citizen engagement in evaluationsThere is a gradual but increasing use of citizen engagement in research evaluation processes around Europe, especially in healthcare, but it remains relatively rare, said Henry Sauermann, a professor at the European School of Management and Technology in Berlin and an expert in citizen science.“Given that we are at a point where citizen involvement is extremely limited, there is presumably space for more, but it's not that we should do it just because we want to do it,” he told Science|Business. He said some research lends itself better to having citizen input, and this usually tends to be on the applied end of the science spectrum where the public can offer useful feedback based on their experiences. He added that advising scientists on certain topics to study is also a useful approach, in the way that Latvia is doing. “The public does fund a lot of science, there's a lot of tax money going into this. We of course do want to preserve academic freedom, but it's also not unreasonable to incorporate more feedback or input from citizens where possible,” he said. Related articlesCitizen science: where, when, and how to let the public contribute to researchHow can Europe cope with a flood of AI-assisted research grant proposals?Data Corner: Horizon Europe’s AI, digital and data call success rate is 5.2%There are several ways of involving citizens in science funding. The most minimal way is having a few representatives on a panel, such as members of a patient group or union. The most direct way is crowdsourcing funding for specific projects. There is an increasing number of online platforms that allow the public to chip in to support scientific proposals.Sauermann studied this in a recent paper and found that it can have its uses, but it still is not clear if there are benefits to it. There are various assumptions linked to citizen engagement, for example that it increases public trust in science, or that it provides a representative view of what the public thinks about science. These are not necessarily true, Sauermann found. People who participate in engagement activities tend to already be very trusting of science, and, on the whole, it is generally the well-off and well educated who contribute, giving a narrow view of public opinion. On whether citizen input can help manage the increasing number of proposals that are being submitted due to assistance from AI, Sauermann is more sceptical. “The obvious answer to the flood of AI-written proposals is AI-driven evaluation,” he said, adding that it doesn’t mean citizen engagement shouldn’t be a part of evaluations in a well thought-out manner. Southern Denmark’s successful approachOne successful example of citizen engagement in science evaluations was implemented in southern Denmark. Between 2019 and 2025, citizens in the region were invited to vote to fund one of five pre-selected projects in the field of healthcare. The project, called A Healthier Southern Denmark, was a collaboration between regional authorities, the University of Southern Denmark, and two media partners. Over the seven years, there were 75,000 votes and significant public engagement online and on social media. “It was a bit of a wild project, we’d never done something like that before and we were a bit nervous about what would be said in the media about it. But actually, people were very positive,” said Anne Kathrine Overgaard, one of the main organisers of the project from the University of Southern Denmark. The university and its researchers have learned a lot from the experience, particularly about engaging with society and shaping their research to match real-world needs. This is important with Europe’s increasing focus on competitiveness and bringing innovations to market faster, Overgaard said. She hopes to see more citizen engagement in evaluation processes and in science more broadly. “For many years, citizen engagement has been a bit of an add-on to proposals, just to check a box. But I think things are changing,” she said. It’s less about citizens just gathering data and more “about the dialogue between the public and the scientists,” she said. The initiative ended last year as the team wanted to regroup to find fresh momentum. The development of AI and AI-written proposals has made Overgaard reflect on how the project could be reworked to help evaluators. She hopes to bring it back in the future. “It could be a good idea to try this initiative again in a slightly re-worked format,” she said.
War, sports collide as Iran's World Cup kicks off in Los Angeles
CBC News reported on the unchartered territory FIFA World Cup 2026 is finding itself in as members of Team Iran arrive in Los Angeles, inviting a divisive collision of geopolitics and sports in an area with a large Iranian diaspora. "You've never had two countries engaged in active military conflict matching up against each other, competing in the same tournament," said Salma Mousa, an assistant professor of political science and affiliated faculty with the Bedari Kindness Institute. Mousa, who studies the intersection of sports and conflicts, worries that a potential July 3 face-off between Iran and the U.S. in Texas might “increase tensions to kind of a cataclysmic degree.” Read more about UCLA in today’s Washington Times.
The Science of Team Science: Lessons Learned from the International Brain Laboratory
The International Brain Laboratory offers insights into how large-scale scientific collaborations can be supported and how the model itself can be improved.
NASCAR's connection between military, fans traces back to the sport's genesis
NASCAR's deep connection between the military, fans and the sanctioning body itself traces back to the sport's genesis.
Jeff Bezos Just Raised $12 Billion. He’s Betting His Newest Business Will Create the Next Elon Musk or Henry Ford
Jeff Bezos is back in an operating seat for the first time since stepping down from Amazon (NASDAQ:AMZN), pointing a $12 billion war chest at what he calls the engine of civilizational wealth: invention itself. In a CNBC interview on June 11, 2026, Bezos and co-CEO Vik Bajaj outlined Prometheus, a Series B round raising ... Jeff Bezos Just Raised $12 Billion. He’s Betting His Newest Business Will Create the Next Elon Musk or Henry Ford
Terminated employee accused of stealing from Lexington business
Police say Wayne Michael Properties in Lexington reported a former employee was forging and issuing checks to himself.
Judge who had sex in courthouse and attended political event agrees to exit Georgia election case
A federal judge who was disciplined after an investigation found that she had sex with a police officer in her chambers and attended a partisan event, then lied when confronted with the allegations, has recused herself in a fight over Georgia election records after the U.S. Department of Justice raised questions about her ability to be impartial.
Judge who had sex in courthouse and attended political event agrees to exit Georgia election case
ATLANTA (AP) — A federal judge who was disciplined after an investigation found that she had sex with a police officer in her chambers and attended a partisan event, then lied when confronted with the allegations, has recused herself in a fight over Georgia election records after the U.S. Departm...
Judge who had sex in courthouse and attended political event agrees to exit Georgia election case
A federal judge has recused herself in a fight over Georgia election records after the U.S. Department of Justice raised questions about her ability to be impartial
Limited Health Literacy Common in Middle-Aged Primary Care Patients
Limited health literacy is common among middle-aged primary care patients and is associated with poorer health self-management skills.
College sports built a new body to police itself. A year later, order has not been restored
The entity that was created in some ways to replace the NCAA has been stuck fighting similar battles in its first year of existence.
Mobileye To Establish Vertically Integrated Robotaxi Business
New initiative extends Mobileye beyond self-driving-system supply and is additive to existing automaker and mobility-partner programs